Brief: Sana Biotechnology Q4 Adjusted EPS USD -0.16 Vs. IBES Estimate USD -0.13
03/03/2026 21:05
Mar 03 (Reuters) - Sana Biotechnology Q4 EPS USD -0.21. Q4 operating expenses USD 61.199 million Q4 adjusted net income USD -44.736 million vs. IBES estimate USD -34.3 million Q4 net income USD -58.825 million
Recent news on Sana Biotechnology
See all newsSana Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Sana Biotechnology Q2 adjusted loss narrows, beats estimates
Brief: Sana Biotechnology Q2 Adjusted EPS USD -0.13 Vs. IBES Estimate USD -0.15
Sana Biotechnology posts Q1 adjusted loss narrower than expected, extends cash runway
Brief: Sana Biotechnology Q1 Adjusted EPS USD -0.14 Vs. IBES Estimate USD -0.17